Increased expression of transforming growth factor-β1 and thrombospondin-1 in congenital hepatic fibrosis: Possible role of the hepatic stellate cell

Journal of Pediatric Gastroenterology and Nutrition

Volumn 28, Issue 4, 1999, Pages 386-392

  El Youssef, Mounif ^a   Mu, Yan ^a   Huang, Lijun ^a   Stellmach, Veronica ^a   Crawford, Susan E ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Congenital hepatic fibrosis; Liver; Stellate cell; Thrombospondin 1; Transforming growth factor 1

Indexed keywords

THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MEDIATOR RELEASE; PATHOGENESIS; PRIORITY JOURNAL; STELLATE CELL;

BLOTTING, WESTERN; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DESMIN; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; LIVER; LIVER CIRRHOSIS; RNA, MESSENGER; THROMBOSPONDINS; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033513343     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199904000-00008     Document Type: Article

References (45)

1. Montgomery-Bissell D, Friedman SL, Maher JJ, Roll FJ. Connective tissue biology and hepatic fibrosis: Report of a conference. Hepatology 1990;3:488-98.
2. Hendricks HFJ, Verhoofstad WAMM, Brouwer A, DeLeeuw AM, Knnok DL. Perisinusoidal fat-strong cells are the main vitamin A storage sites in rat liver. Exp Cell Res 1985;160:138-49.
3. Gressner AM, Bachem MG. Cellular sources of non-collagenous matrix proteins: Roll of fat storing cells in fibrogenesis. Semin Liver Dis 1990;10:3-46.
4. Friedman SL. Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis 1990;10:20-9.
5. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: The principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 1985;82:8681-5.
6. Maher JJ, Friedman SL, Roll FJ, Bissell DM. Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lymphocytes in primary culture. Gastroenterology 1988;94: 1053-62.
7. Mack KM, Lieber CS. Lipocytes and transitional cells in alcoholic stliver disease: A morphometric study. Hepatology 1988;8:1027-33.
8. Mack KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: Transformation of lipocytes to transitional cells. Gastroenterology 1984;87:188-200.
9. Arenson DM, Friedman SL, Bissell DM. Formation of extracellular matrix in normal rat liver: Lipocytes as a major source of proteoglycan. Gastroenterology 1988;95:441-7.
10. Schaffer S, Zerbe O, Gressner AM. The synthesis of proteoglycans in fat storing cells of rat liver. Hepatology 1987;7:680-7.
11. Biagini G, Ballardini G. Liver fibrosis and extracellular matrix. J Hepatol 1989;8:115-24.
12. Friedman SL, Arthur MJP. Activation of cultured rat hepatic lipocytes by Kupffer cell condition medium: Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet derived growth factor receptors. J Clin Invest 1989;84: 1780-5.
13. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor β1 modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-904.
14. Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte production by Kupffer cell derived transforming growth factor beta: Implications for pathogenic role in alcoholic liver fibrogenesis. Hepatology 1990;11:599-605.
15. Armendariz-Borunda J, Seyer JM, Kang AH, Raghow R. Regulation of transforming growth factor β expression in rat liver intoxicated with carbon tetracholoride. FASEB J 1990;4:215-21.
16. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell D. Maintenance of differentiated phenotype of cultured rat hepatic stellate cells by basement membrane matrix. J Biol Chem 1989;164: 10756-62.
17. Murphy-Ullrich JE, Schultz-Cherry S, Hook M. Transforming growth factor beta complexes with thrombospondin. Mol Biol Cell 1992;3:181-8.
18. Schultz-Cherry S, Chen H, Mosher DF, et al. Regulation of transforming growth factor βactivation by discreet sequences of thrombospondin-1. J Biol Chem 1995;270:7304-10.
19. 1 in vivo. Cell 1998;93: 1159-70.
20. Hayashi K, Kurohiji T, Shirouzu K. Localization of thrombospondin in hepatocellular carcinoma. Hepatology 1997;25:569-74.
21. Picolli DA, Witzleben CL. Disorders of intrahepatic bile ducts. Pediatr Intest Dis 1991;2:1124-40.
22. Desmet VJ. Embryology of the liver and intrahepatic biliary tract, and an overview of malformations of the bile duct. In: MacIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. The Oxford Textbook of Clinical Hepatology. Oxford, England: Oxford University Press, 1991:497-519.
23. Hammar JA. Uber die erste eentstehung der nicht kapillaren eintrahepatischen gallengange beim menschen. Z Mmirrosk Anat Forsch 1926;5:59-89.
24. Jorgensen MJ. The ductal plate malformation: A study of the intrahepatic bile duct lesion in infantile polycystic disease and congenital hepatic fibrosis. Acta Pathol Microbiol Scand 1977;257(Suppl A):1-88.
25. Desmet VJ. Congenital diseases of the intra-hepatic bile ducts: Variations on the theme "ductal plate malformation." Hepatology 1982;16:1069-83.
26. Desmet VJ. What is congenital hepatic fibrosis? Histopathology 1992;20:465-77.
27. Nauta J, Ozawa Y, Sweeney WE, Rutledge JC, Avner ED. Renal and biliary abnormalities and a new murine model of autosomal recessive polycystic kidney disease. Pediatr Nephrol 1993;7:163-72.
28. Murray-Lyon IM, Ockenden BJ, Williams J. Congenital hepatic fibrosis: Is it a single clinical entity? Gastroenterology 1973;64: 653-6.
29. Welling LW, Grantham JJ. Cystic and developmental diseases of the kidney. In: Brenner BM, Rector FC Jr. eds. The Kidney. 2nd ed. Philadelphia: W.B. Saunders, 1991:33-6.
30. Baenziger NL, Brodie GN, Majerus PW. Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem 1972;247:2723-31.
31. Iruela-Arispe ML, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 1991;88:5026-30.
32. Murphy-Ullrich JE, Hook M. Thrombospondin modulates focal adhesion in endothelial cells. J Cell Biol 1989;109:1309-19.
33. Taraboletti G, Roberts D., Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential agiogenesis regulatory factor. J Cell Biol 1990; 111:765-72.
34. Segeeh, Varnon RV. Regulation of angiogenesis by extracellular matrix: The growth and the glue. J Hypertension 1994;10(Suppl 12);S145-52.
35. Mahjer JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat stellate cells in sinusoidal endothelial cells during hepatic fibrosis in-vivo. J Clin Invest 1990;86:1641-8.
36. Gressner Am. Cytokines in cellular cross-talk involved in the activation of fat storing cells. J Hepatol 1995;22(Suppl 2):28-36.
37. Barnad JA, Lyons RM, Moses HL. The cell biology of TGF β. Biochem Biophys Res Commun 1990;170:867-72.
38. Czaja MJ, Weinwe FR, Flanders KC, et al. In vitro and in vivo association of TGF β with hepatic fibrosis. J Cell Biol 1989;108: 2477-82.
39. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. TGF β1 and TGF β2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991;139:1221-9.
40. Weiner FR, Giambrone MA, Czaja MJ, et al. Ito cell gene expression and collagen regulation. Hepatology 1990;11:111-7.
41. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by TGF β derived from myofibroblast like cells. J Clin Invest 1992;89:19-27.
42. Maasague J, Cheifetz M, Laiho M, Ralph A, Weis FMB, Zentella A. Transforming growth factor β. Cancer Surv 1992;12:81-163.
43. Schultz-Cherry S, Murphy-Ulrich JE. Thrombospondin causes activation of latent transforming growth factor β secreted by endothelial cells by a novel mechanism. J Cell Biol 1993;122:923-32.
44. Barnad JA, Lyons RM, Moses HL. The cell biology of TGF β Biochem Biophys Res Commun 1990;170:867-72.
45. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. TGF β1 and TGF β2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991;139:1221-9.